Clinical Trial Detail

NCT ID NCT02915666
Title A Clinical Trial of Patients With Melanoma
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors University of Texas Southwestern Medical Center
Indications

melanoma

Therapies

Dabrafenib + Digoxin + Trametinib

Age Groups: adult senior

Additional content available in CKB BOOST